The non-neuronal cholinergic system as novel drug target in the airways

Life Sciences

Volumn 91, Issue 21-22, 2012, Pages 1113-1118

  Pieper, Michael Paul ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Acetylcholine; Anticholinergic; Cholinergic tone; Inflammation; Muscarinic; Remodeling

Indexed keywords

ACLIDINIUM BROMIDE; ANTIINFLAMMATORY AGENT; ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; FLUTROPIUM BROMIDE; GLYCOPYRRONIUM BROMIDE; IPRATROPIUM BROMIDE; MUSCARINIC RECEPTOR; OXITROPIUM BROMIDE; ROFLUMILAST; SALMETEROL; STEROID; TIOTROPIUM BROMIDE; ACETYLCHOLINE; MUSCARINIC RECEPTOR BLOCKING AGENT;

AIRWAY; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATING ACTIVITY; BRONCHOSPASM; CHOLINERGIC SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; COUGHING; DOSE RESPONSE; DRUG ABSORPTION; DRUG HALF LIFE; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; EOSINOPHILIA; EXPERIMENTAL MODEL; HUMAN; HYPERSENSITIVITY; MUCUS SECRETION; NONHUMAN; OBSTRUCTIVE AIRWAY DISEASE; RECEPTOR BINDING; RECEPTOR SENSITIVITY; RESPIRATORY TRACT DISEASE; SIGNAL TRANSDUCTION; UNSPECIFIED SIDE EFFECT; ANIMAL; DRUG EFFECT; IMMUNOLOGY; INNERVATION; LUNG; METABOLISM; METHODOLOGY; MOLECULARLY TARGETED THERAPY; REVIEW;

ACETYLCHOLINE; ANIMALS; ASTHMA; HUMANS; LUNG; MOLECULAR TARGETED THERAPY; MUSCARINIC ANTAGONISTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, MUSCARINIC;

EID: 84872760578     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.08.030     Document Type: Conference Paper

References (42)

1. P.J. Barnes The role of anticholinergics in chronic obstructive pulmonary disease Am J Med 117 Suppl. 12A 2004 24S 32S
2. P.J. Barnes, and I.M. Adcock Glucocorticoid resistance in inflammatory diseases Lancet 373 9678 2009 1905 1917
3. E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, and M. FitzGerald Global strategy for asthma management and prevention: GINA executive summary Eur Respir J 31 1 2008 143 178
4. I.S. Bos, R. Gosens, A.B. Zuidhof, D. Schaafsma, A.J. Halayko, and H. Meurs Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison Eur Respir J 30 4 2007 653 661
5. V. Brusasco Reducing cholinergic constriction: the major reversible mechanism in COPD Eur Respir Rev 15 99 2006 32 36
6. F. Bühling, N. Lieder, U.C. Kühlmann, N. Waldburg, and T. Welte Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro Respir Med 101 11 2007 2386 2394
7. P. Casarosa, T. Bouyssou, S. Germeyer, A. Schnapp, F. Gantner, and M. Pieper Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs J Pharmacol Exp Ther 330 2 2009 660 668
8. K.R. Chapman History of anticholinergic tratment in airways diseases N.J. Gross, Anticholinergic therapy in obstructive airways disease 1993 Franklin Scientific Publications London 9 18
9. J. Cortijo, M. Mata, J. Milara, E. Donet, A. Gavaldà, and M. Miralpeix Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways Eur Respir J 37 2 2011 244 254
10. G. Damera, M. Jiang, H. Zhao, H.W. Fogle, W.F. Jester, and J. Freire Aclidinium bromide abrogates allergen-induced hyperresponsiveness and reduces eosinophilia in murine model of airway inflammation Eur J Pharmacol 649 1-3 2010 349 353
11. P.V. Dicpinigaitis, L. Spinner, G. Santhyadka, and A. Negassa Effect of tiotropium on cough reflex sensitivity in acute viral cough Lung 186 6 2008 369 374
12. B. Disse, R. Reichl, G. Speck, W. Traunecker, K.L. Ludwig Rominger, and R. Hammer Ba 679 BR, a novel long-acting anticholinergic bronchodilator Life Sci 52 5-6 1993 537 544
13. J.V. Fahy, and B.F. Dickey Airway mucus function and dysfunction N Engl J Med 363 23 2010 2233 2247
14. R. Gosens, I.S. Bos, J. Zaagsma, and H. Meurs Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling Am J Respir Crit Care Med 171 10 2005 1096 1102
15. S.A. Grando, K. Kawashima, and I. Wessler Introduction: the non-neuronal cholinergic system in humans Life Sci 72 18-19 2003 2009 2012
16. N.J. Gross Anticholinergic agents in asthma and COPD Eur J Pharmacol 533 1-3 2006 36 39
17. N.J. Gross, E. Co, and M.S. Skorodin Cholinergic bronchomotor tone in COPD Chest 96 5 1989 984 987
18. G. Jositsch, T. Papadakis, R.V. Haberberger, M. Wolff, J. Wess, and W. Kummer Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice Naunyn Schmiedebergs Arch Pharmacol 379 4 2009 389 395
19. H.A. Kerstjens, B. Disse, W. Schröder-Babo, T.A. Bantje, and M. Gahlemann Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial J Allergy Clin Immunol 128 2 2011 308 314
20. S. Koyama, S.I. Rennard, and R.A. Robbins Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity Am J Physiol 262 4 Pt 1 1992 L466 L471
21. L.Y. Lee, and B.J. Undem Mechanisms of chronic cough Pulm Pharmacol Ther 17 6 2004 463 464
22. S. Matthiesen, A. Bahulayan, S. Kempkens, S. Haag, M. Fuhrmann, and C. Stichnote Muscarinic receptors mediate stimulation of human lung fibroblast proliferation Am J Respir Cell Mol Biol 35 6 2006 621 627
23. J. Milara, A. Serrano, T. Peiró, A. Gavaldà, M. Miralpeix, and E.J. Morcillo Aclidinium inhibits human lung fibroblast to myofibroblast transition Thorax 67 3 2011 229 237
24. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study Lancet 349 9064 1997 1498 1504
25. S. Ohta, N. Oda, T. Yokoe, A. Tanaka, Y. Yamamoto, and Y. Watanabe Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma Clin Exp Allergy 40 8 2010 1266 1275
26. A. Pahl, A. Bauhofer, U. Petzold, P.J. Cnota, J. Maus, and K. Brune Synergistic effects of the anti-cholinergic R,R-glycopyrrolate with anti-inflammatory drugs Biochem Pharmacol 72 12 2006 1690 1696
27. T. Pera, A. Zuidhof, J. Valadas, M. Smit, R.G. Schoemaker, and R. Gosens Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD Eur Respir J 38 4 2011 789 796
28. S.P. Peters, S.J. Kunselman, N. Icitovic, W.C. Moore, R. Pascual, and B.T. Ameredes National Heart, Lung, and Blood Institute Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma N Engl J Med 363 18 2010 1715 1726
29. M.P. Pieper, N.I. Chaudhary, and J.E. Park Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide Life Sci 80 24-25 2007 2270 2273
30. D.J. Powrie, T.M. Wilkinson, G.C. Donaldson, P. Jones, K. Scrine, and K. Viel Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD Eur Respir J 30 3 2007 472 478
31. M. Profita, R.D. Giorgi, A. Sala, A. Bonanno, L. Riccobono, and F. Mirabella Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients Allergy 60 11 2005 1361 1369
32. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, and P. Calverley Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 6 2007 532 555
33. P. Santus, C. Buccellati, S. Centanni, F. Fumagalli, P. Busatto, and F. Blasi Bronchodilators modulate inflammation in chronic obstructive pulmonary disease subjects Pharmacol Res 66 4 2012 343 348
34. T. Takahashi, M.G. Belvisi, H. Patel, J.K. Ward, S. Tadjkarimi, and M.H. Yacoub Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways Am J Respir Crit Care Med 150 6 Pt 1 1994 1640 1645
35. D.P. Tashkin, B. Celli, S. Senn, D. Burkhart, S. Kesten, and S. Menjoge A 4-year trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 15 2008 1543 1554
36. K.J. Tracey The inflammatory reflex Nature 420 6917 2002 853 859
37. T. Troosters, B. Celli, T. Lystig, S. Kesten, S. Mehra, and Uplift Investigators Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial Eur Respir J 36 1 2010 65 73
38. C. Vogelmeier, B. Hederer, T. Glaab, H. Schmidt, M.P. Rutten-van Mölken, and K.M. Beeh Tiotropium versus salmeterol for the prevention of exacerbations of COPD N Engl J Med 364 12 2011 1093 1103
39. I.K. Wessler, and C.J. Kirkpatrick The Non-neuronal cholinergic system: an emerging drug target in the airways Pulm Pharmacol Ther 14 6 2001 423 434
40. I. Wessler, C.J. Kirkpatrick, and K. Racké The cholinergic 'pitfall': acetylcholine, a universal cell molecule in biological systems, including humans Clin Exp Pharmacol Physiol 26 3 1999 198 205
41. L. Wollin, and M.P. Pieper Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD Pulm Pharmacol Ther 23 4 2010 345 354
42. M. Yoshida, K. Masunaga, Y. Satoji, Y. Maeda, T. Nagata, and A. Inadome Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in urothelium and its clinical significance J Pharmacol Sci 106 2 2008 193 198